Access and benefit-sharing of the pathogenic microorganisms such as SARS-CoV-2

WHO, What is the WHO BioHub System?. https://www.who.int/initiatives/who-biohub, 2021 (accessed 15 March 2021). Kelly-Cirino, 2019, Importance of diagnostics in epidemic and pandemic preparedness, BMJ Glob. Health, 4, 10.1136/bmjgh-2018-001179 UNESCO, Recommendation on Open Science. https://unesdoc.unesco.org/ark:/48223/pf0000379949.locale=en, 2021 (accessed 28 July 2021). U.N., Convention on biological diversity. https://www.cbd.int/doc/legal/cbd-en.pdf, 1992 (accessed 16 June 2021). Jiang, 2020, Protection of microbial diversity and preservation of pathogenic microbial resources, Biotic. Resour., 38, 322 Liu, 2011 Sirakaya, 2019, Balanced options for access and benefit-sharing: stakeholder insights on provider country legislation, Front. Plant Sci., 10, 10.3389/fpls.2019.01175 United Nations, Nagoya Protocol on access to genetic resources and the fair and equitable sharing of benefits arising from their utilization to the Convention on Biological Diversity. https://www.cbd.int/abs/doc/protocol/nagoya-protocol-en.pdf, 2011 (accessed 3 September 2020). CPMA, 2020, General principles of description for pathogenic microorganism collection (T/CPMA 011-2020), Chin. J. Epidemiol., 41, 1791 WHO, Pandemic influenza preparedness framework for the sharing of influenza viruses and access to vaccines and other benefits, 2nd ed., 2021. https://www.who.int/publications/i/item/9789240024854, 2021 (accessed 16 June 2021). Ren, 2019, On the implementation of Global Solidarity Principle from Pandemic Influenza Preparedness Framework, Medicine and Jurisprudence, 11, 9 WHO, Standard material transfer agreement 2. https://www.who.int/initiatives/pandemic-influenza-preparedness-framework/standard-material-transfer-agreement-2-(smta2), 2016 (accessed 3 September 2021). WHO, Pandemic Influenza Preparedness Framework: 18-month progress report, January 1 2020–June 30 2021. https://www.who.int/publications/i/item/9789240037168, 2021 (accessed 16 June 2021). Feiyue, 2021, International legal practice of equitable distribution of COVID-19 vaccine and China’s response measures, Med. Jurisprudence, 13, 1 Sett, 2022, Access and benefit-sharing by the European Virus Archive in response to COVID-19, Lancet Microbe, 3, e316, 10.1016/S2666-5247(21)00211-1 WHO, Review of the pandemic influenza preparedness framework. https://apps.who.int/iris/handle/10665/274774, 2016 (accessed 28 June 2021). Li, 2020, Expanding the pandemic influenza preparedness framework to the epidemic of COVID-19, Zhonghua Yu Fang Yi Xue Za Zhi, 54, 597 WHO, WHO Technical Consultation Series - WHO BioHub System: Researchers' needs and contributions to the future pandemic system, 2021. https://cdn.who.int/media/docs/default-source/campaigns-and-initiatives/biohub/who-biohub-system-research-theme-background-document.pdf?sfvrsn=e8cca019_5, 2021 (accessed 1 November 2021). WHO, WHO BioHub System. https://cdn.who.int/media/docs/default-source/campaigns-and-initiatives/biohub/20210923_who-biohub-pilot-testing-package-vfinal-for-webposting.pdf?sfvrsn=313e13b7_4, 2021 (accessed 18 October 2021). Baker, 2008, supporting antiviral research, Antiviral Res., 80, 102, 10.1016/j.antiviral.2008.07.003 Molestina, 2010, BEI Resources: a biological resource center for parasitologists, Trends Parasitol., 26, 559, 10.1016/j.pt.2010.09.003 CDC, USDA, Federal Select Agent Program. https://www.selectagents.gov/index.htm, 2020 (accessed 18 March 2021). CDC, USDA, Annual Report of the Federal Select Agent Program. https://www.selectagents.gov/resources/publications/annualreport/2020.htm, 2020 (accessed 25 October 2021). Zhai, 2021, Investigation and analysis on the preservation capacity of pathogen resources in China, Chinese J. Exp. Clin. Virol., 35, 514 Q. Wei, Y. Wang, J. Ma, J. Han, M. Jiang, W. Tan, G. Wu, G.F. Gao, J. Liu, etc., Description of the first strain of 2019-nCoV, C-Tan-nCoV Wuhan Strain - National Pathogen Resource Center, China, 2020, China CDC Wkly. 2 (2020) 81-82, https://doi.org/10.46234/ccdcw2020.023. Jiang, 2021, Interpretation for the group standard of the requirements for preservation of SARS-CoV-2 samples, Chin. J. Viral Dis., 11, 87 CPMA, 2021, Requirements for preservation of SARS-CoV-2 samples (T/CPMA 019-2020), Chin. J. Public Health, 37, 385 E.V. Archive, The EVAg project. https://www.european-virus-archive.com/evag-project, 2021 (accessed 16 June 2021). Baronti, 2020, The importance of biobanking for response to pandemics caused by emerging viruses: The European virus archive as an observatory of the global response to the Zika virus and COVID-19 Crisis, Biopreserv. Biobanking, 18, 561, 10.1089/bio.2020.0119 Hai, 2012, International legislation on benefit sharing of biological genetic resources and the construction of Chinese system, World Agric., 2012, 45 Fuwei, 2021 Cervo, 2016, Drafting biological material transfer agreement: a ready-to-sign model for biobanks and biorepositories, Int. J. Biol. Markers, 31, e211, 10.5301/jbm.5000190 Peeling, 2020, Need for sustainable biobanking networks for COVID-19 and other diseases of epidemic potential, Lancet Infect. Dis., 20, e268, 10.1016/S1473-3099(20)30461-8